"10.1371_journal.pone.0120614","plos one","2015-03-20T00:00:00Z","Mark A Bernard; Leyu Wang; Souvenir D Tachado","Department of Target Biology, Pfizer Oligonucleotide Therapeutics Unit, Cambridge South Campus, Cambridge, Massachusetts, United States of America; Department of Protein Biology, Pfizer Global Biotherapeutics Technology Unit, Cambridge North Campus, Cambridge, Massachusetts, United States of America; Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America","Conceived and designed the experiments: MAB. Performed the experiments: MAB. Analyzed the data: MAB. Contributed reagents/materials/analysis tools: MAB LW. Wrote the paper: MAB LW SDT.","MAB and LW received salary from Pfizer Inc. but are no longer affiliated with Pfizer. There are no patents, products in development or marketed products to declare. This does not alter the authorsâ€™ adherence to all PLOS ONE policies on sharing data and materials.","2015","03","Mark A Bernard","MAB",3,TRUE,1,1,1,3,TRUE,TRUE,FALSE,0,NA,FALSE
